Evaluation of Hemo Techt NS-Plus system for use in a province-wide colorectal cancer screening program

Canadian Cancer Society's Steering Committee on Cancer Statistics, 2011 Monnet, 1998, Comparability of colorectal cancer survival data in three European population based registries, Eur J Cancer Prev, 7, 127 Winawer, 2002, The advanced adenoma as the primary target of screening, Gastrointest Endosc Clin N Am, 12, 1, 10.1016/S1052-5157(03)00053-9 Jorgensen, 2002, A randomised study of screening for colorectal cancer using faecal occult blood testing: results after 13 years and seven biennial screening rounds, Gut, 50, 29, 10.1136/gut.50.1.29 Mandel, 1999, Colorectal cancer mortality: effectiveness of biennial screening for fecal occult blood, J Natl Cancer Inst, 91, 434, 10.1093/jnci/91.5.434 Hewitson, 2007, Screening for colorectal cancer using the faecal occult blood test, Hemoccult, Cochrane Database Syst Rev, CD001216 Hardcastle, 1996, Randomised controlled trial of faecal-occult-blood screening for colorectal cancer, Lancet, 348, 1472, 10.1016/S0140-6736(96)03386-7 Levin, 2011, Organized colorectal cancer screening in integrated health care systems, Epidemiol Rev, 33, 101, 10.1093/epirev/mxr007 Faivre, 2012, Comparison between a guaiac and three immunochemical faecal occult blood tests in screening for colorectal cancer, Eur J Cancer, 10.1016/j.ejca.2012.04.007 Wong, 2012, The sensitivity and specificity of guaiac and immunochemical fecal occult blood tests for the detection of advanced colonic adenomas and cancer, Int J Colorectal Dis, 10.1007/s00384-012-1518-3 Rabeneck, 2012, Fecal immunochemical tests compared with guaiac fecal occult blood tests for population-based colorectal cancer screening, Can J Gastroenterol, 26, 131, 10.1155/2012/486328 Leddin, 2010, Canadian Association of Gastroenterology position statement on screening individuals at average risk for developing colorectal cancer: 2010, Can J Gastroenterol, 24, 705, 10.1155/2010/683171 Heitman, 2010, Colorectal Cancer Screening for Average-Risk North Americans: An Economic Evaluation, PLoS Med, 10.1371/journal.pmed.1000370 Telford, 2010, The cost-effectiveness of screening for colorectal cancer, CMAJ, 182, 1307, 10.1503/cmaj.090845 Hundt, 2009, Comparative evaluation of immunochemical fecal occult blood tests for colorectal adenoma detection, Ann Intern Med, 150, 162, 10.7326/0003-4819-150-3-200902030-00005 Oono, 2010, A retrospective study of immunochemical fecal occult blood testing for colorectal cancer detection, Clin Chim Acta, 411, 802, 10.1016/j.cca.2010.02.057 Kim, 2010, Evaluation of Hemo Techt NS-plus C15 automatic analyzer for fecal occult blood test, J Lab Med Qual Assur, 32, 237 Yamagata, 2006, A comparison of six models of commercially available automated immunologic fecal occult blood analyzers, J Clin Lab Instru Reag, 29, 1 Vilkin, 2005, Performance characteristics and evaluation of an automated-developed and quantitative, immunochemical, fecal occult blood screening test, Am J Gastroenterol, 100, 2519, 10.1111/j.1572-0241.2005.00231.x Rozen, 2006, Evaluation of a desk top instrument for the automated development and immunochemical quantification of fecal occult blood, Med Sci Monit, 12, MT27 van Roon, 2012, Are fecal immunochemical test characteristics influenced by sample return time? A population-based colorectal cancer screening trial, Am J Gastroenterol, 107, 99, 10.1038/ajg.2011.396 Rozen, 2010, Cumulative evaluation of a quantitative immunochemical fecal occult blood test to determine its optimal clinical use, Cancer, 116, 2115 Goede, 2012, Cost-effectiveness of one versus two sample faecal immunochemical testing for colorectal cancer screening, Gut Quintero, 2012, Colonoscopy versus fecal immunochemical testing in colorectal-cancer screening, N Engl J Med, 366, 697, 10.1056/NEJMoa1108895